PDCD1 and neoplasm: Immune evasion mechanisms such as loss of MHC class I molecules [1088], downregulation of death receptors [1222], and immune checkpoint pathways like PD-1/PD-L1 [1223] also hamper antigen presentation and immune killing of stem-like tumor cells.